69 research outputs found

    RETRATO SIN IDENTIFICAR [Material gráfico]

    Get PDF
    Copia digital. Madrid : Ministerio de Educación, Cultura y Deporte, 201

    Occupational choice of return migrants in Moldova

    Get PDF
    This paper analyzes the occupational choice of return migrants. Using the survey data on different aspects of migration in Moldova, we find that those who stayed illegally in the host country tend to go into wage employment on return to the home country. We also show that relatively better educated migrants tend not to be in formal employment (i.e., appear not to participate in the labor market), whereas those with relatively lower skills or who obtained a worse-than-expected outcome in the host country are more likely to be wage employed in the home country on return. We offer an economic analysis of these paradoxical results

    The efficacy of four-slice helical CT in evaluating pancreatic trauma: a single institution experience

    Get PDF
    <p>Abstract</p> <p>Study objective</p> <p>To assess the efficacy of computed tomography (CT) in evaluating patients with pancreatic trauma.</p> <p>Methods</p> <p>We undertook a retrospective review of all blunt trauma patients admitted to the Chi-Mei Medical Center from January 2004 to June 2006. Every patients underwent abdominal CT scan in emergency department and the CT scans were obtained with a four-slice helical CT. Diagnosis of a pancreatic injury in these patients was by surgical observation or by CT findings. Radiographic pancreatic injuries were classified as deep or superficial lesions. Deep lesions were defined as the hematomas or lacerations >50% thickness of the pancreas. Superficial lesions were described as the hematomas or lacerations <50% thickness of the pancreas; pancreatic edema; and focal fluid accumulation around the pancreas</p> <p>Results</p> <p>Nineteen patients with pancreatic trauma, fourteen males and five females, average age 40.6 ± 21.4 years, were included. Most patients (73.7%) with pancreatic trauma had associated organ injuries. CT was performed in all patients and laparotomy in 14 patients. CT was 78.9% sensitive in detecting pancreatic trauma. All deep pancreatic lesions revealed on CT required surgical treatment, and complication was discovered in two patients undergoing delayed surgery. Superficial lesions were managed conservatively.</p> <p>Conclusion</p> <p>Four-slice helical CT can detect most pancreatic trauma and provide practical therapeutic guidance. Delayed operation might result in complications and is associated with prolonged hospital stays.</p

    Misogyny, racism, and Islamophobia: street harassment at the intersections

    Get PDF
    Veiled Muslim women are at an increased risk of street harassment in the current political and economic climate. Their visibility, combined with their popular portrayal as culturally dangerous or threatening means that they are vulnerable to receiving verbal and physical threats, which can be misogynistic and Islamophobic in nature. Drawing on 60 individual and 20 focus group interviews with Muslim women in the United Kingdom who wear the niqab (face veil) and had experienced harassment in public, this qualitative study details their lived experiences. It argues that an intersectional analysis is crucial to understanding the nuances of their lived experiences and the impact street harassment has on their lives. The findings demonstrate that street harassment can produce a hostile environment for veiled Muslim women, which can have a terrorizing effect, limiting their full participation in the public sphere

    Geotagged application for durian trees using aerial imagery and vegetation indices algorithm

    Get PDF
    Durian demand has increased considerably, and it has gained popularity in the market. Under Industrial Revolution 4.0, precision agriculture is expanding globally with a wide range of digital technologies that provide the farming industry with information to improve farm productivity. The objectives of this study are to geotag the durian trees and to compare several Vegetation Indices (VIs) algorithms (VisibleBand Difference Vegetation Index (VDVI), Visible Atmospherically Resistant Index (VARI), Normalized Green-Red Difference Index (NGRDI), Red-Green Ratio Index (RGRI), Modified Green-Red Vegetation Index (MGRVI), Excess Green Index (ExG), Color Index of Vegetation (CIVE), and Vegetativen (VEG)). One hundred sixty durian trees at the Durian Valley in Kluang (Johor), were tagged, which consist of four sample trees for each treatment. Every two weeks of ground data such as the height of trees, canopy width, girth’s diameter, node distance, pH value, moisture content, electrical conductivity (EC) reading, and leaf sizes were exported into the QGIS software and joined with the tagged durian trees. The aerial imagery data captured the durian plantation area using Red Green Blue (RGB) sensor with a 100 m flight attitude. pH, EC, and moisture content were interpolated using Inverse Distance Weighted (IDW) technique. The processed image by VIs and geotagged trees could help farmers to identify the problem areas in the farm and monitor durian plantation effectively

    IMPACT-Global Hip Fracture Audit: Nosocomial infection, risk prediction and prognostication, minimum reporting standards and global collaborative audit. Lessons from an international multicentre study of 7,090 patients conducted in 14 nations during the COVID-19 pandemic

    Get PDF

    Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Get PDF
    Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.
    corecore